Torrent Pharmaceuticals advances on launching its biosimilar Adalimumab in India

13 Jan 2016 Evaluate

Torrent Pharmaceuticals is currently trading at Rs. 1455.00, up by 24.25 points or 1.69% from its previous closing of Rs. 1430.75 on the BSE.

The scrip opened at Rs. 1440.00 and has touched a high and low of Rs. 1456.00 and Rs. 1436.20 respectively. So far 3766 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1720.00 on 01-Sep-2015 and a 52 week low of Rs. 1033.00 on 27-Feb-2015.

Last one week high and low of the scrip stood at Rs. 1456.00 and Rs. 1409.45 respectively. The current market cap of the company is Rs. 24621.91 crore.

The promoters holding in the company stood at 71.25% while Institutions and Non-Institutions held 18.46% and 10.30% respectively.

Torrent Pharmaceuticals has launched its biosimilar Adalimumab in India, used for the treatment of auto immune disorders, under the brand name ‘Adfrar’. The company’s product will be available as pre-filled syringe of 40 mg.

Adalimumab is a preferred therapy for the treatment of auto immune disorders and has wide applications for treatment of rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis and plaque psoriasis among others.

Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.


Torrent Pharma Share Price

3781.55 -20.10 (-0.53%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×